Tissue inhibitor of metalloproteinases-4 is expressed in cervical cancer patients

Anticancer Research

Volumn 25, Issue 1 B, 2005, Pages 623-627

  Lizarraga, Floria ^a   Espinosa, Magali ^a   Maldonado, Vilma ^a   Melendez Zajgla, Jorge ^a  

^a INSTITUTO NACIONAL DE CANCEROLOGÍA   (Mexico)

Author keywords

Cervical cancer; TIMP 4

Indexed keywords

TISSUE INHIBITOR OF METALLOPROTEINASE 4;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER GROWTH; CANCER STAGING; CHI SQUARE DISTRIBUTION; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; EXTRACELLULAR MATRIX; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; INHIBITION KINETICS; METASTASIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SQUAMOUS EPITHELIUM; TUMOR GROWTH; UTERINE CERVIX CANCER;

ADULT; AGED; AGED, 80 AND OVER; CELL LINE, TUMOR; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; DNA, COMPLEMENTARY; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM METASTASIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TISSUE DISTRIBUTION; TISSUE INHIBITOR OF METALLOPROTEINASES; TRANSFECTION; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL; UTERINE CERVICAL NEOPLASMS;

EID: 16344370727     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Stamenkovic I: Matrix metalloproteinases in tumor invasion and metastasis. Semin Cancer Biol 10: 415-33, 2000.
2. Gomez DE, Alonso DF, Yoshiji H and Thorgeirsson UP: Tissue inhibitors of metalloproteinases: structure, regulation and biological functions. Eur J Cell Biol 74: 111-22, 1997.
3. Brew K, Dinakarpandian D and Nagase H: Tissue inhibitors of metalloproteinases: evolution, structure and function. Biochim Biophys Acta 1477: 267-83, 2000.
4. Brand K: Cancer gene therapy with tissue inhibitors of metalloproteinases (TIMPs). Curr Gene Ther 2: 255-71, 2002.
5. Mannello F and Gazzanelli G: Tissue inhibitors of metalloproteinases and programmed cell death: conundrums, controversies and potential implications. Apoptosis 6: 479-82, 2001.
6. Jiang Y, Goldberg ID and Shi YE: Complex roles of tissue inhibitors of metalloproteinases in cancer. Oncogene 21: 2245-52, 2002.
7. Greene J, Wang M, Liu YE, Raymond LA, Rosen C and Shi YE: Molecular cloning and characterization of human tissue inhibitor of metalloproteinase 4. J Biol Chem 271: 30375-80, 1996.
8. Jiang Y, Wang M, Celiker MY, Liu YE, Sang QX, Goldberg ID and Shi YE: Stimulation of mammary tumorigenesis by systemic tissue inhibitor of matrix metalloproteinase 4 gene delivery. Cancer Res 61: 2365-70, 2001.
9. Tunuguntla R, Ripley D, Sang QX and Chegini N: Expression of matrix metalloproteinase-26 and tissue inhibitors of metalloproteinases TIMP-3 and -4 in benign endometrium and endometrial cancer. Gynecol Oncol 89: 453-9, 2003.
10. Groft LL, Muzik H, Rewcastle NB, Johnston RN, Knauper V, Lafleur MA, Forsyth PA and Edwards DR: Differential expression and localization of TIMP-1 and TIMP-4 in human gliomas. Br J Cancer 85: 55-63, 2001.
11. Asha Nair S, Karunagaran D, Nair MB and Sudhakaran PR: Changes in matrix metalloproteinases and their endogenous inhibitors during tumor progression in the uterine cervix. J Cancer Res Clin Oncol 129: 123-31, 2003.
12. Sheu BC, Lien HC, Ho HN, Lin HH, Chow SN, Huang SC and Hsu SM: Increased expression and activation of gelatinolytic matrix metalloproteinases is associated with the progression and recurrence of human cervical cancer. Cancer Res 63: 6537-42, 2003.
13. Hernandez P, Olivera P, Duenas-Gonzalez A, Perez-Pastenes MA, Zarate A, Maldonado V and Melendez-Zajgla J: Gemcitabine activity in cervical cancer cell lines. Cancer Chemother Pharmacol 48: 488-92, 2001.
14. Bandala E, Espinosa M, Maldonado V and Melendez-Zajgla J: Inhibitor of apoptosis-1 (IAP-1) expression and apoptosis in non-small-cell lung cancer cells exposed to gemcitabine. Biochem Pharmacol 62: 13-9, 2001.
15. Melendez J, Maldonado V, Bingle CD, Selman M and Pardo A: Cloning and expression of guinea pig TIMP-2. Expression in normal and hyperoxic lung injury. Am J Physiol Lung Cell Mol Physiol 275: L737-43, 2000.
16. Leco KJ, Apte SS, Taniguchi GT, Hawkes SP, Khokha R, Schultz GA and Edwards DR: Murine tissue inhibitor of metalloproteinases-4 (Timp-4): cDNA isolation and expression in adult mouse tissues. FEBS Lett 401: 213-7, 1997.
17. Nuovo GJ: In situ detection of PCR-amplified metalloproteinase cDNAs, their inhibitors and human papillomavirus transcripts in cervical carcinoma cell lines. Int J Cancer 71: 1056-60, 1997.
18. Davidson B, Goldberg I, Liokumovich P, Kopolovic J, Gotlieb WH, Lerner-Geva L, Reder I, Ben-Baruch G and Reich R: Expression of metalloproteinases and their inhibitors in adenocarcinoma of the uterine cervix. Int J Gynecol Pathol 17: 295-301, 1998.
19. Formenti S, Felix J, Salonga D, Danenberg K, Pike MC and Danenberg P: Expression of metastases-associated genes in cervical cancers resected in the proliferative and secretory phases of the menstrual cycle. Clin Cancer Res 6: 4653-7, 2000.
20. Davidson B, Goldberg I, Kopolovic J, Lerner-Geva L, Gotlieb WH, Ben-Baruch G and Reich R: MMP-2 and TIMP-2 expression correlates with poor prognosis in cervical carcinoma - a clinicopathologic study using immunohistochemistry and mRNA in situ hybridization. Gynecol Oncol 73: 372-82, 1999.
21. Span PN, Lindberg RL, Manders P, Tjan-Heijnen VC, Heuvel JJ, Beex LV and Sweep CF: Tissue inhibitors of metalloproteinase expression in human breast cancer: TIMP-3 is associated with adjuvant endocrine therapy success. J Pathol 202: 395-402, 2004.
22. Zhao YG, Xiao AZ, Park HI, Newcomer RG, Yan M, Man YG, Heffelfinger SC and Sang QX: Endometase/matrilysin-2 in human breast ductal carcinoma in situ and its inhibition by tissue inhibitors of metalloproteinases-2 and -4: a putative role in the initiation of breast cancer invasion. Cancer Res 64: 590-8, 2004.
23. Wang M, Liu YE, Greene J, Sheng S, Fuchs A, Rosen EM and Shi YE: Inhibition of tumor growth and metastasis of human breast cancer cells transfected with tissue inhibitor of metalloproteinase 4. Oncogene 14: 2767-74, 1997.
24. Guedez L, McMarlin AJ, Kingma DW, Bennett TA, Stetler-Stevenson M and Stetler-Stevenson WG: Tissue inhibitor of metalloproteinase-1 alters the tumorigenicity of Burkitt's lymphoma via divergent effects on tumor growth and angiogenesis. Am J Pathol 158: 1207-15, 2001.
25. Wang T, Yamashita K, Iwata K and Hayakawa T: Both tissue inhibitors of metalloproteinases-1 (TIMP-1) and TIMP-2 activate Ras but through different pathways. Biochem Biophys Res Commun 296: 201-5, 2002.
26. Guedez L, Stetler-Stevenson WG, Wolff L, Wang J, Fukushima P, Mansoor A and Stetler-Stevenson M: In vitro suppression of programmed cell death of B cells by tissue inhibitor of metalloproteinases-1. J Clin Invest 102: 2002-10, 1998.
27. Nemeth JA and Goolsby CL: TIMP-2, a growth-stimulatory protein from SV40-transformed human fibroblasts. Exp Cell Res 207: 376-82, 1993.
28. Sounni NE, Janssen M, Foidart JM and Noel A: Membrane type-1 matrix metalloproteinase and TIMP-2 in tumor angiogenesis. Matrix Biol 22: 55-61, 2003.
29. Sang QX: Complex role of matrix metalloproteinases in angiogenesis. Cell Res 8: 171-7, 1998.